Gilead opens new research centre bringing together oncology, inflammation and research data science teams
Article excerpt
Gilead Sciences has opened its 182,000-square-foot Research Center at its Foster City, California headquarters, expanding capabilities in oncology, inflammation and research data science to advance medicines for some of the world’s most challenging diseases. The company currently employs approximately 11,000 people across the US, including more than 7,400 in California and nearly 4,700 in the San FranciscoBay Area. The centre marks the latest milestone in the company’s $32bn investment in US research, development and manufacturing up until 2030 Gilead marked the milestone with a ribbon-cutting ceremony attended by company leaders, scientists and government and community guests. Daniel O’Day, Chairman and CEO of Gilead Sciences, said: “We are in a moment of unprecedented opportunity in science and technology. Our new Research Center will help Gilead scientists make the most of that opportunity, delivering more breakthrough medicines faster.” Designed with input from Gilead research colleagues, the five-story centre will support approximately 325 employees, including 260 laboratory scientists. Flexible laboratory neighbourhoods, specialised collaboration spaces and shared technology platforms will enable teams to adapt as scientific needs evolve. All-electric systems, energy-efficient design and water-saving landscaping featuring California native plants are expected to...
Keep reading with a free account
The rest of this article, and every signal for Gilead, is in your free account.
Extracted from this sentence
The other two projects include the Technical Development Center, expected to open in 2027, and the biologics facility, which broke ground in August and is expected to open in 2029.
